Plain-English translation of NCT07358806 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new cancer drug called . Researchers want to find the right dose of this medication that works well and is safe for patients with advanced solid tumors like breast, lung, head and neck, prostate, or stomach cancer. The trial will also test whether the medication works better when combined with a standard chemotherapy drug.
Many people with advanced cancers need better treatment options. This medication targets a specific pathway in cancer cells, and this trial will help doctors understand if it can help patients whose cancer is no longer responding to standard treatments.
You likely qualify if…
You likely don't qualify if…
In Part A, you would take the medication by mouth once a day, starting at a low dose. Researchers gradually increase the dose in different groups of patients to find the safest level. In Part B, you would take the medication combined with a standard chemotherapy drug called docetaxel. You would have regular visits for blood tests, imaging scans, and check-ups to monitor how you're responding and watch for side effects.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
South Korea